Nevertheless, the available literature on ACE2 expression and its clinical significance in CRC remains scarce, and the extant reports have limitations, including small sample sizes, an absence of validation using independent clinical samples, and a dearth of molecular mechanism investigations. The gene discussed is ACE2; the disease is colorectal carcinoma.